World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, 

Abstract

ATRIAL FIBRILLATION IN COPD

Rubina Kausar*, Iffat Batool and Mehak Fatima

ABSTRACT

Objective; To assess the frequency of atrial fibrillation in cases presenting with COPD. Material and methods; This was a cross sectional study that was carried out at Surraya Azeem Hospital, Lahore & Aziz Bhatti Shaheed teaching hospital, Gujrat during the July to December 2018. There were 400 patients included. The cases were labelled as COPD according to GOLD 2015 guidelines. Atrial fibrillation was labelled as yes on the basis of absent p wave and irregular heart rate. Results; In the present study, there were total 400 cases of COPD, out of which 328 (82%) were males and 72 (8%) were females. The mean age at presentation was 57.11±9.82 years. There were 232 (58%) cases that had COPD for more than 3 years and 272 (68%) of cases had class IV of COPD. Atrial fibrillation was seen in 72 (18%) of the cases. Atrial fibrillation was seen in 52 (22.41%) out of 232 cases that had COPD more than 3 years with p= 0.02. There was no significant difference in terms of severity of COPD where it was seen in 20 (15.62%) cases with class III and 52 (19.12%) cases of class IV out of their respective groups with p= 0.43. Conclusion; Atrial fibrillation is not uncommon complication of COPD and it is significantly associated with duration of COPD more than 5 years.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here